ClinicalTrials.gg
CompletedNCT06944093Updated Apr 25, 2025

Listen to a Audio Book

An interventional study of audio book in Respiratory Failure With Hypercapnia, sponsored by Ataturk University. Completed at 1 site in Turkey. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-25.

Sponsored by Ataturk University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled May 2024, registered Mar 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study investigates how listening to audiobooks affects agitation scores and respiratory parameters (like breathing rate, depth, and oxygen saturation) in patients receiving non-invasive mechanical ventilation (NIMV) for hypercapnic respiratory failure in an intensive care unit. Participants will listen to an audiobook of their choice during their 2-hour NIMV treatment. Their agitation levels and respiratory parameters will be measured before, during, and after NIMV application. The goal is to evaluate whether audiobooks can reduce patient agitation and improve respiratory outcomes, offering a low-cost, easy-to-use, and effective approach for better patient care.

02

Conditions studied

  • Respiratory Failure With Hypercapnia

Browse trials for

03

In context

Hypercapnia

156 studies on the registry are indexed under Hypercapnia; 31 are open to participants now.

This study's enrollment of 42 is above the median of 36 across 120 interventional studies indexed under Hypercapnia.

Browse Hypercapnia studies →

Lead sponsor

Ataturk University is the lead sponsor of 458 studies on the registry; 124 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Patients aged 18 years or older Patients hospitalized in the Chest Diseases Intensive Care Unit Diagnosed with Hypercapnic Respiratory Failure Undergoing Non-invasive Mechanical Ventilation (NIMV) No hearing impairment Conscious and alert patients

Exclusion criteria

Exclusion Criteria:

Patients unwilling to participate or wishing to withdraw from the study

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
42 participants (actual)

Study arms

  • Experimental
    Experimental

    Listen to a audio book

    Behavioral: audio book

  • No intervention
    Control

Interventions

  • Behavioralaudio book

    Listen to a audio book

06

What researchers measure

Primary outcomes

  1. Agitation Scores

    Time frame: 10 month

  2. Breathing Rate

    Time frame: 10 month

  3. Breathing Depth

    Time frame: 10 month

  4. SpO₂ Levels

    Time frame: 10 month

07

Study locations

1 site
  • Atatürk University Faculty of Nursing
    Erzurum, 25000, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06944093
Lead sponsor
Ataturk University
Responsible party
Burak YAVUZ (Principal Investigator, Ataturk University) — Principal investigator
First posted
Apr 25, 2025
Start date
May 1, 2024
Primary completion
Sep 1, 2024
Completion
Mar 1, 2025
Last update
Apr 25, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion